
	Where results make sense

Topic: Drug Efficacy Study Implementation

Related Topics

War on Drugs

Food and Drug Administration

drug addiction

recreational drug use

Illegal drugs

recreational drugs

drug abuse

Illegal drug trade

hallucinogenic drugs

Drug Enforcement Administration

drug overdose

drug traffickers

In the News (Sat 28 Nov 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	FDAReview.org, a project of The Independent Institute: FDA Glossary
		Drug loss is difficult to measure, although Peltzman’s (1973) results (see also the discussion in the text) suggest that it is very extensive.
		Under the Food, Drug, and Cosmetic Act of 1938, the NDA was submitted to the FDA enumerating the uses of the drug and providing evidence of its safety.
		Drugs to reduce cholesterol, for example, are intended ultimately to reduce the number of heart attacks and thus to lengthen life expectancy.
	www.fdareview.org /glossary.shtml (7941 words)

	FEP 807
		All drugs added to the formulary are noted in their respective levels of the drug lists throughout this formulary.
		Drugs first marketed between 1938 and 1962 were approved as safe but required no showing of effectiveness for FDA approval.
		The Drug Efficacy Study Implementation (DESI) program was established by the FDA to review the effectiveness of these pre-1962 drugs for their labeled indications, and a determination of fully effective was made for most of these products and they remain in the marketplace.
	www.advancerx.com /Formulary/00807/f807m.htm (1977 words)

	AMA (CSAPH) Featured Report: Enhanced Physician Access to FDA Data (A-05) Full Text
		Measures to Expand Access. In 1983, the Orphan Drug Act was passed, enabling the FDA to promote research and marketing of drugs and biologics needed for treating rare diseases with a population prevalence of less than 200,000.
		In the absence of formal postmarketing studies, (spontaneous) observational data are the cornerstone for evaluating and characterizing a drug’s risk profile in actual clinical use.
		A serious adverse drug reaction is defined as one that results in or prolongs hospitalization, is life-threatening, contributes to significant disability, or results in the death of the patient.
	www.ama-assn.org /ama/pub/category/15152.html (3214 words)

	Less Than Effective (LTE) and Identical, Related and Similar (IRS) Drugs
		However, once a manufacturer changed the representation on a pre-38 drug's label, that drug was considered by the Food and Drug Administration to be a "new drug" and the manufacturer was required to prove that the drug was safe for its intended use.
		At that time, a manufacturer of that drug or identical, related or similar (IRS) drugs has the opportunity to request a hearing and provide FDA with documentation of the effectiveness of the drug product before a final determination is made.
		Drugs for which a NOOH has been published are referred to as less-than-effective (LTE) drugs.
	cms.hhs.gov /MedicaidDrugRebateProgram/12_LTEIRSDrugs.asp (501 words)

	21 CFR 310--NEW DRUGS
		A drug exempted from the prescription requirement under the provisions of paragraph (b) of this section is a ``new drug'' within the meaning of section 201(p) of the act until it has been used to a material extent and for a material time under such conditions except as provided in paragraph (e) of this section.
		Other studies have shown that there is a sufficient correlation between bioavailability in vivo and the dissolution rate of digoxin tablets in vitro to make the dissolution test an important addition to the compendial standards.
		The Food and Drug Administration recommends that, where digoxin tablets are reformulated, manufacturers reformulate their product to achieve dissolution of 70 to 90 percent at one hour when tested by all three methods (i.e., the USP method, and the ``paddle-water'' and ``paddle-acid'' methods) described in paragraph (h) of this section.
	www1.va.gov /oro/apps/compendium/Files/21CFR310.htm (11802 words)

	FDA > CDRH > CFR Title 21 Database Search
		All persons with an interest in a product that is identical, related, or similar to a drug listed in a drug efficacy notice or a notice of opportunity for a hearing will be given the same opportunity as the applicant to submit data and information, to request a hearing, and to participate in any hearing.
		However, it is essential that the findings and conclusions that a drug product is a "new drug" or that there is a lack of evidence to show that a drug product is safe or effective be applied to all identical, related, and similar drug products to which they are reasonably applicable.
		In many instances a determination can readily be made as to the applicability of a drug efficacy notice by an individual who is knowledgeable about drugs and their indications for use.
	www.accessdata.fda.gov /scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=310.6 (677 words)

	Missing 3761-501,
		Any eligible claimant whose prescription drug costs are covered in part by any other plan of assistance or insurance may be required to receive reduced assistance under the provisions of this chapter.
		An A-rated generic therapeutically equivalent drug is deemed by the department, in consultation with a utilization review committee, to have too narrow a therapeutic index for safe and effective dispensing in the community setting.
		The Department of Health has determined that a drug shall not be recognized as an A-rated generic therapeutically equivalent drug for purpose of substitution under section 5(b) of the act of November 24, 1976 (P.L. 1163, No. 259), referred to as the Generic Equivalent Drug Law.
	www.aging.state.pa.us /aging/lib/aging/72PS3761.htm (5430 words)

	Tufts CSDD
		Because sales of orphan drugs are likely to be small compared to their development costs, pharmaceutical companies are awarded exclusive rights to market these medicines for a period of time as an incentive to develop them.
		Pharmacodynamics is the study of the biochemical and physiological effects of drugs on the organism and the relationship between drug concentration and effect, i.e.
		Studies that are essential to receive FDA approval for a new drug but which the FDA believes will yield important data on the newly marketed drug.
	csdd.tufts.edu /InfoServices/Glossary.asp (2222 words)

	Homeopathic Drugs, Royal Copeland, and Federal Drug Regulation
		While the safety of homeopathic drugs under the FDCA drew no regulatory scrutiny, passage of the 1962 Kefauver-Harris amendments in the wake of thalidomide, did generate questions about the extent to which homeopathic drugs should be required to conform to the law's new efficacy provisions [131].
		In 1994, a citizen petition was submitted to FDA requesting that it hold homeopathic drugs to the same standards of safety and efficacy as other drugs regulated by the agency [167].
		Drugs or devices deemed dangerous to health under the conditions of use prescribed in the labeling were prohibited from interstate commerce.
	www.homeowatch.org /history/reghx.html (11644 words)

	Penicillin adverse reactions and penicillin alergies not when did alexander discover penicillin or who invent it the ... (Site not responding. Last check: 2007-10-13)
		Drugs derived from penicillin of cozaar manufacturer not penicillin hypersensitivity of nifedipine cut in half not severe strep infection of the body penicillin amoxicillin dosing.
		Penicillin and cephalsporin allergies.generic drug for topamax penicillin mp3.theophylline effect on myocardium and neuromuscular transfer or drug class penicillin doxycycline dosage for urinary tract infections.
		Accidental discovery of penicillin, drug efficacy study implementation and fentanyl penicillins psychological effects or verapamil hydrochloride' and solubility and pfizer penicillin production during wwii of generic adderall pictures 132.
	gynandrous.pcadsl.com.tw /penicillin.html (3093 words)

	University Of Michigan Benefits Office
		Drug Efficacy Study Implementation Program (DESI) drugs as determined by the FDA (Food and Drug Administration) as lacking substantial evidence of effectiveness.
		The DESI drugs do not have studies to back up the medications' uses, but since they have been used and accepted for many years without significant safety problems, they continue to be used in today's marketplace.
		New drugs are subject to review by SXC and the University before being covered or excluded.
	www.umich.edu /~benefits/plans/drugs/coverage.htm (787 words)

	Combination Doxylamine Succinate Plus Pyridoxine Hydrochloride
		When the drug was reviewed in the Food and Drug Administration’s Drug Efficacy Study Implementation program, however, it was determined that dicyclomine hydrochloride did not contribute to the efficacy of the other two ingredients.
		Because the drug combination was placed on the list, a pharmaceutical company can file a new drug application to receive approval to market the drug in the United States.
		According to the December 1999 update to Drugs in Pregnancy and Lactation, the doxylamine monograph has been revised to reflect a new Pregnancy category risk factor rating of “A.” An “A” rating means that safety has been established using human studies.
	www.uspharmacist.com /oldformat.asp?url=newlook/files/Drug/drugforum.cfm&pub_id=8&article_id=616 (771 words)

	Barr Pharmaceuticals, Inc.
		The generic drug industry can trace its founding to the mid-1960s, when an effort by the government to prove the safety and effectiveness of pharmaceuticals manufactured prior to 1962 opened the door for the full-scale development of generic products.
		In 1962 the National Research Council of the National Academy of Sciences was instructed to evaluate all drugs that had been approved for use prior to 1962.
		The study also found that while good for consumers, generic competition has also been good for innovation within America’s brand pharmaceutical industry.
	www.barrlabs.com /generic/history.php (475 words)

	FR Doc 03-20241
		Background In 1962, Congress amended the new drug provisions, which then applied to new drugs intended for both man and other animals, to require that a new drug be shown to be both safe and effective before marketing (the Drug Amendments of 1962, Public Law 87-781, 76 Stat.
		Under the DESI program, a new animal drug approved before October 10, 1962, could continue to be approved if the sponsor submitted a supplemental NADA to revise the indications for use to those for which the agency determined the drug to be effective.
		This document announces the effective indications for which certain new animal drugs and drug combinations may be marketed, and provides an opportunity for hearing on those indications for which products may not be marketed because they lack substantial evidence of effectiveness.
	a257.g.akamaitech.net /7/257/2422/14mar20010800/edocket.access.gpo.gov/2003/03-20241.htm (4406 words)

	The usefulness of Iodine
		In relation to supplemental use of iodine, my studies of certain dairy herds has revealed interesting evidences of the relationship between host and microorganisms, viruses, insects, and other parasites.With one herd the veterinary bill had generally run $150.00 and sometimes more a year.
		The object of this study was to learn whether little children got sick on an alkaline urine or on an acid urine background.
		In the herd of dairy cows I studied, I decreased the bacteria count of the milk markedly, as I have shown previously, by adding three drops of iodine to two ounces of apple cider vinegar, the whole poured over the ration of each cow at every feeding twice a day.
	www.jcrows.com /iodine.html (6642 words)

	FR Doc 02-32344
		The 1979 notice stated that, according to bioavailability studies submitted by Beecham, the relative bioavailability or extent of absorption of a 250-mg capsule was 56-62 percent of that of the 200-mg intramuscular injection.
		Labeling was to state, among other things, that the drug was indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.
		The notice further stated that any such drug product labeled for the indications lacking substantial evidence of effectiveness specified in the notice could not thereafter lawfully be marketed, and the agency would initiate appropriate regulatory action to remove any such drug products from the market (44 FR 2017 at 2020).
	a257.g.akamaitech.net /7/257/2422/14mar20010800/edocket.access.gpo.gov/2002/02-32344.htm (1503 words)

	Electronic Code of Federal Regulations:
		Applicability of ''new drug'' or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.
		Continuation of long-term studies, records, and reports on certain drugs for which new drug applications have been approved.
		Drug products containing active ingredients offered over-the-counter (OTC) for external use as hair growers or for hair loss prevention.
	ecfr.gpoaccess.gov /cgi/t/text/text-idx?c=ecfr&tpl=/ecfrbrowse/Title21/21cfr310_main_02.tpl (473 words)

	Als drug protocols - Drug trialsStacking the deck : Nature (Site not responding. Last check: 2007-10-13)
		In Japanese protocols the effects of these drugs are assessed in many aspects It may be the central part in assessing the drug effect for ALS patients.
		IV ALS drugs were administered in 74%, 82% were intubated, and additional defibrillation by medics was performed in 44%.
		ALS is a fatal neuromuscular disease characterized by the chronic, under a Treatment Investigational New Drug protocol approved by the FDA in June 1996.
	justseeks.com /jssk/als-drug-protocols.htm (1237 words)

	Development of Alternatives to Animal Use for Safety Testing and Hazard Assessment
		Both types of studies began to reveal interesting differences in the manner in which various species metabolized certain chemicals, calling into question the basic assumption that responses observed in rodents were valid predictors of human toxicity.
		A few studies indicated that some animal tests were not as reliable as predictors of human response as was commonly assumed (Weil and Scala, 1971).
		Validation studies in progress were methodologically flawed, critics charged, because they failed to conform to the rigorous standards which were established as early as the Amden meeting.
	www.solutions-site.org /artman/publish/article_67.shtml (6868 words)

	Campaign For New Drug Policies
		Proposition 36, approved in November 2000, changed state law so that certain drug offenders would receive drug treatment and supervision in the community rather than being sent to jail, which is far more costly.
		36 implementation joined in a letter to the governor and legislative leaders to argue against changing the ballot measure’s guaranteed funding and oversight provisions.
		Supporters of the law, requiring drug treatment instead of jail for drug possession, vowed to sue if the proposal is not withdrawn.
	www.drugreform.org (892 words)

	Conservation Science at The Nature Conservancy - Conservation Science Publications - Papers on Conservation Science - ...
		Drawing from case studies around the world to illustrate our framework, we suggest that ecologically sustainable water management is attainable in the vast majority of the world's river basins.
		In a nine-year study, we investigated the effectiveness of exclosures to control browsing and improve establishment and early recruitment of eastern white pine.
		Find more reports and studies at ConserveOnline, a "one-stop" online public library that was created and is maintained by The Nature Conservancy in partnership with other conservation organizations.
	nature.org /tncscience/docs (2977 words)

	Page 37
		To further comply with the drug amendments of 1962 the FDA contracted in 1966 with the National Academy of Sciences/National Research Council to study drugs approved between 1938 and 1962 from the standpoint of efficacy.
		The Drug Efficacy Study Implementation (DESI) evaluated over 3000 separate products and over 16,000 therapeutic claims.
		One of the early effects of the DESI study was the development of the Abbreviated New Drug Application (ANDA).
	www.fda.gov /cder/about/history/page37.htm (184 words)

	Drug Store Directory Blog
		Researchers at the Brown Cancer Center, University of Louisville, Kentucky, studied the synergistic effects of Imprime PGG in combination with Avastin in a xenograft mouse model where human ovarian cancer cells were implanted into the mice.
		Avastin is the first U.S. Food and Drug Administration (FDA) approved therapy designed to inhibit angiogenesis, the process by which new blood vessels develop and carry vital nutrients to a tumor.
		Avastin is approved, in combination with intravenous 5-fluorouracil-based (5-FU) chemotherapy, for first- or second-line treatment of patients with metastatic carcinoma of the colon or rectum and in combination with carboplatin and paclitaxel for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC).
	www.drug-store-directory.com /drug-store-blog (2025 words)

	MI Bibliography
		Drug and Alcohol Dependence, 77, 49-59.Hettema, J., Steele, J., and Miller, W. Motivational interviewing.
		Graeber, D.A., Moyers, T. B., Griffith, G., Guajardo, E. and Tonigan, S. A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders.
		Drug abuse treatment through collaboration: Practice and research partnerships that work.
	www.motivationalinterview.org /library/biblio.html (8889 words)

	FDA Announces that Companies Must Stop Marketing Suppository Products Containing Trimethobenzamide
		As part of the Food and Drug Administration's (FDA) on-going initiative to ensure that all marketed U.S. drugs have required marketing approval, the agency announced today that companies must stop manufacturing and distributing unapproved suppository drug products containing trimethobenzamide hydrochloride.
		In 1962, Congress amended the Federal Food, Drug, and Cosmetic Act to require that drugs be shown to be effective, as well as safe.
		"Prescription drugs that have not gone through the FDA approval process are of unproven safety and effectiveness," said director of CDER's Office of Compliance, Deborah M. Autor.
	www.fda.gov /bbs/topics/NEWS/2007/NEW01601.html (575 words)

	EDC: Search > Search by Topic
		In the four-year ICARE Schools study, EDC is identifying and documenting middle-grades schools that use innovative approaches to engage all families in the education of students with disabilities,...
		EDC is conducting a three-year pilot feasibility study of a school- and community-based media campaign to correct misperceptions of high school student drinking norms.
		This project is assisting selected campuses in implementing a social norms marketing campaign to reduce alcohol use among students on campus and 18- to 25-year-olds working in the local community.
	main.edc.org /Search/theme.asp?themeID=3 (9489 words)

	W3C Semantic Web Health Care and Life Sciences
		Drug Discovery Technology August 7-10, 2006, Boston, MA.
		Key to their success is the implementation of new informatics models that will unite many forms of biological and medical information across all institutions, through the encoding of meaning into the data and their interpretations.
		Jan 25-26 F2F Meeting, five new task forces have been drafted to address key areas necessary for implementation of semantic web for healthcare and life sciences.
	www.w3.org /2001/sw/hcls (1625 words)

Try your search on: Qwika (all wikis)